News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TetraPhase Pharmaceuticals To Present At Upcoming Investor Conferences


3/21/2014 7:15:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing a portfolio of potent new antibiotics designed to be effective against drug-resistant bacteria, today announced presentations at two upcoming investor conferences. The Company's lead antibiotic candidate, eravacycline, is currently in Phase 3 development to treat multidrug-resistant (MDR) infections, including those caused by many of the MDR Gram-negative bacteria highlighted as urgent public health threats by the Centers for Disease Control and Prevention (CDC).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES